By flow cytometry assays, we found that HRG overexpression cancer cells inhibited CD11b+Ly6G+ neutrophils, while HRG knockdown cancer cells and KO‐HRG mice enhanced the percentage of CD11b+Ly6G+ neutrophils rather than other immune cells (Figures 3B and C). This evidence concerns the gene ITGAM and cancer.